Translation and validation of the Nepean Dyspepsia Index for functional dyspepsia in China.

AIM To assess the reliability and validity of the translated version of Nepean Dyspepsia Index (NDI) in Chinese patients with documented functional dyspepsia (FD). METHODS The translation process included forward translation, back translation, pretest and cross-cultural adaptation. Reliability and validity of the translated version were examined by asking 300 subjects to complete the Chinese version of the NDI. The mean age of subjects was 39.24 years and 68.7% of the subjects were women. Internal consistency analysis with Cronbach's alpha was performed to test the reliability. Correlation analysis was used to assess the content validity. Factor analysis and structural equation models were used to assess the construct validity. RESULTS The Cronbach's alpha coefficients ranged 0.833-0.960, well above the acceptable level of 0.70. Correlation analysis showed that each item had a strong correlation with the corresponding domain, but a weak correlation with other domains. Confirmatory factor analysis indicated that the comparative fit index was 0.94, higher than the acceptable level of 0.90. CONCLUSION The Chinese version of the NDI is a reliable and valid scale for measuring health-related quality of life and disease severity in Chinese patients with FD.

[1]  D. De Looze,et al.  Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[2]  H. Gooszen,et al.  Functional dyspepsia and irritable bowel syndrome in patients with achalasia and its association with non-cardiac chest pain and a decreased health-related quality of life , 2009, Scandinavian journal of gastroenterology.

[3]  L. Kupčinskas,et al.  Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[4]  Jana G Hashash,et al.  Clinical trial: a randomized controlled cross‐over study of flupenthixol + melitracen in functional dyspepsia , 2008, Alimentary pharmacology & therapeutics.

[5]  N. Talley,et al.  Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials , 2007, Gut.

[6]  P. Malfertheiner,et al.  Drug treatment of functional dyspepsia. , 2006, World journal of gastroenterology.

[7]  N. Talley,et al.  A placebo-controlled trial of itopride in functional dyspepsia. , 2006, The New England journal of medicine.

[8]  S. Miehlke,et al.  Management of functional dyspepsia: Unsolved problems and new perspectives. , 2005, World journal of gastroenterology.

[9]  L. Low,et al.  Validity and reliability of the SF-36: the Malaysian context. , 2005, The Medical journal of Malaysia.

[10]  Myung-Gyu Choi,et al.  [The effect of mosapride on quality of life in functional dyspepsia]. , 2004, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

[11]  H. El‐Serag,et al.  The prevalence and clinical course of functional dyspepsia , 2004, Alimentary pharmacology & therapeutics.

[12]  A. Zinsmeister,et al.  Impact of functional gastrointestinal disorders on health‐related quality of life: a population‐based case–control study , 2004, Alimentary pharmacology & therapeutics.

[13]  G. Holtmann,et al.  Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six‐week placebo‐controlled, double‐blind, multicentre trial , 2003, Alimentary pharmacology & therapeutics.

[14]  G. Boeckxstaens,et al.  The proximal stomach and postprandial symptoms in functional dyspeptics , 2002, American Journal of Gastroenterology.

[15]  N. Talley,et al.  Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? , 2001, American Journal of Gastroenterology.

[16]  C. Boland,et al.  American Gastroenterological Association. Our new president--Jon I. Isenberg, M.D. , 2001, Gastroenterology.

[17]  N. Talley,et al.  Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10‐item short form , 2001, Alimentary pharmacology & therapeutics.

[18]  D. Drossman,et al.  The functional gastrointestinal disorders and the Rome III process. , 1999, Gastroenterology.

[19]  N. Talley,et al.  Validity of a new quality of life scale for functional dyspepsia: a United States multicenter trial of the Nepean Dyspepsia Index , 1999, American Journal of Gastroenterology.

[20]  Wyeth,et al.  Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index , 1999, Alimentary pharmacology & therapeutics.

[21]  P. Moayyedi,et al.  The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia , 1998, Alimentary pharmacology & therapeutics.

[22]  A. Sonnenberg,et al.  AGA technical review: Evaluation of dyspepsia ☆ ☆☆ , 1998 .

[23]  R. Hays,et al.  Psychometric considerations in evaluating health-related quality of life measures , 1993, Quality of Life Research.

[24]  J. S. Long,et al.  Testing Structural Equation Models , 1993 .

[25]  M. Browne,et al.  Alternative Ways of Assessing Model Fit , 1992 .

[26]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[27]  P. Bentler,et al.  Cutoff criteria for fit indexes in covariance structure analysis : Conventional criteria versus new alternatives , 1999 .

[28]  P. Wahlqvist,et al.  Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study. , 1999, Scandinavian journal of gastroenterology.

[29]  A. Sonnenberg,et al.  AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. , 1998, Gastroenterology.

[30]  N. Talley.  Quality of life in functional dyspepsia. , 1996, Scandinavian journal of gastroenterology. Supplement.

[31]  Ware J.E.Jr.,et al.  THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .